---
title: "Dual C5aR1 and C5aR2 loss separates neutrophil influx from antibacterial function in lung infection"
id: "biorxiv-10-dual-c5ar1-and-c5ar2-deficiency-uncouples-neutrophilic-inflammation-from"
canonical_url: "https://medichelpline.com/clinical-feed/biorxiv-10-dual-c5ar1-and-c5ar2-deficiency-uncouples-neutrophilic-inflammation-from"
content_type: "clinical_feed_article"
specialty: "Pulmonology"
source_name: "bioRxiv (Biomedical Preprints)"
source_url: "https://www.biorxiv.org/content/10.64898/2026.11.19.767710v1?rss=1"
published_at: "2026-11-20T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Dual C5aR1 and C5aR2 loss separates neutrophil influx from antibacterial function in lung infection
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/biorxiv-10-dual-c5ar1-and-c5ar2-deficiency-uncouples-neutrophilic-inflammation-from
- **Specialty:** [Pulmonology](https://medichelpline.com/clinical-feed/pulmonology.md)
- **Primary Source:** bioRxiv (Biomedical Preprints)
- **Source URL:** [Original Journal Publication](https://www.biorxiv.org/content/10.64898/2026.11.19.767710v1?rss=1)
- **Published At:** 2026-11-20T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Investigators examined the roles of complement receptors **C5aR1** and **C5aR2** in pulmonary defense against Streptococcus pneumoniae. - The study team identified alveolar type II epithelial cells as a local source of **C5** in the lung. - Authors reported that mice lacking **C5** showed increased susceptibility to pneumococcal infection. - Combined genetic deficiency of **C5aR1** and **C5aR2** removed C5a-driven lung inflammation, according to the preprint. - Paradoxically, dual receptor deficiency produced greater neutrophil accumulation during infection than either single-receptor loss. - Despite marked recruitment, **neutrophils** from dual-deficient mice had impaired bacterial clearance and produced excessive extracellular traps; the cohort developed worse lung injury and higher mortality. - Single-cell CITE-seq data indicated broad dysregulation of neutrophils and macrophages, revealing neutrophil subclusters with defective antimicrobial programs, elevated cell death, and altered inflammatory signatures consistent with functional exhaustion. - The authors concluded that **C5aR1** and **C5aR2** provide complementary, partially non-redundant signals that link **neutrophil** recruitment to antimicrobial competence and limit tissue-damaging inflammation. - The report is a preprint and has not been peer reviewed; the manuscript did not report detailed dosing, time courses, or other experimental parameters in the abstract.
## Clinical Analysis & Structured Key Points
Dual C5aR1 and C5aR2 deficiency uncouples neutrophilic inflammation from antibacterial host defense | bioRxiv Skip to main content New Results Dual C5aR1 and C5aR2 deficiency uncouples neutrophilic inflammation from antibacterial host defense View ORCID Profile Sarah Walachowski , View ORCID Profile Archana Jayaraman , View ORCID Profile Vanessa Tansi , View ORCID Profile Markus Dudek , View ORCID Profile Neha Chaudhary , Shuang Xu , View ORCID Profile Federico Marini , View ORCID Profile Matthias Gunzer , View ORCID Profile Christoph Reinhardt , View ORCID Profile Markus Bosmann doi: https://doi.org/10.64898/2026.11.19.767710 Sarah Walachowski 1 Pulmonary Center, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Sarah Walachowski Archana Jayaraman 2 Pulmonary Center, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, 02118, MA, USA; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Archana Jayaraman Vanessa Tansi 3 Center for Thrombosis and Hemostasis, University Medical Center Mainz, 55131 Mainz, Germany; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Vanessa Tansi Markus Dudek 3 Center for Thrombosis and Hemostasis, University Medical Center Mainz, 55131 Mainz, Germany; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Markus Dudek Neha Chaudhary 2 Pulmonary Center, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, 02118, MA, USA; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Neha Chaudhary Shuang Xu 2 Pulmonary Center, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, 02118, MA, USA; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Federico Marini 4 Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center Mainz, Mainz, Germany; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Federico Marini Matthias Gunzer 5 Institute for Experimental Immunology and Imaging, University Hospital, University Duisburg-Essen, Essen 45122, Germany Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Matthias Gunzer Christoph Reinhardt 3 Center for Thrombosis and Hemostasis, University Medical Center Mainz, 55131 Mainz, Germany; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Christoph Reinhardt Markus Bosmann 1 Pulmonary Center, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Markus Bosmann For correspondence: mbosmann{at}bu.edu Abstract Info/History Metrics Supplementary material Preview PDF Abstract Streptococcus pneumoniae is a major cause of bacterial pneumonia and mortality worldwide. While host defense critically depends on complement activation, how C5aR1 and C5aR2 orchestrate pulmonary antibacterial immunity remains unclear. We identified alveolar type II epithelial cells as a local source of C5 and confirmed increased susceptibility of C5-deficient mice to infection. Combined C5aR1/C5aR2 deficiency abolished C5a-induced lung inflammation but paradoxically exacerbated neutrophil accumulation during pneumococcal infection, exceeding that observed in either single-receptor deficiency. Despite their abundance, neutrophils exhibited impaired bacterial clearance, excessive extracellular trap formation, accompanied by aggravated lung injury and mortality. CITE-seq revealed profound neutrophil and macrophage dysregulation, identifying distinct neutrophil subclusters with defective antimicrobial programs, increased cell death and altered inflammatory signatures, consistent with functional exhaustion. Thus, C5aR1 and C5aR2 exert complementary, partially non-redundant functions that couple neutrophil recruitment to antimicrobial competence, prevent excessive inflammation, and preserve effective pulmonary host defense. Competing Interest Statement The authors have declared no competing interest. Funder Information Declared This work was supported by the National Institutes of Health (R01HL139641 to M.B), the Federal Ministry of Education and Research (01EO1503 to M.B.). and the Deutsche Forschungsgemeinschaft (German Research Foundation, Project number 318346496 - SFB1292/3 TP19 to F.M.). This manuscript is the result of funding in whole or in part by the National Institutes of Health (NIH). It is subject to the NIH Public Access Policy. Through acceptance of this federal funding, NIH has been given a right to make this manuscript publicly available in PubMed Central upon the Official Date of Publication, as defined by NIH. Copyright The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Back to top Previous Posted November 20, 2026. Download PDF Supplementary Material Email Thank you for your interest in spreading the word about bioRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Dual C5aR1 and C5aR2 deficiency uncouples neutrophilic inflammation from antibacterial host defense Message Subject (Your Name) has forwarded a page to you from bioRxiv Message Body (Your Name) thought you would like to see this page from the bioRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Dual C5aR1 and C5aR2 deficiency uncouples neutrophilic inflammation from antibacterial host defense Sarah Walachowski , Archana Jayaraman , Vanessa Tansi , Markus Dudek , Neha Chaudhary , Shuang Xu , Federico Marini , Matthias Gunzer , Christoph Reinhardt , Markus Bosmann bioRxiv 2026.11.19.767710; doi: https://doi.org/10.64898/2026.11.19.767710 Share This Article: Copy Citation Tools Dual C5aR1 and C5aR2 deficiency uncouples neutrophilic inflammation from antibacterial host defense Sarah Walachowski , Archana Jayaraman , Vanessa Tansi , Markus Dudek , Neha Chaudhary , Shuang Xu , Federico Marini , Matthias Gunzer , Christoph Reinhardt , Markus Bosmann bioRxiv 2026.11.19.767710; doi: https://doi.org/10.64898/2026.11.19.767710 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Area Immunology Subject Areas All Articles Animal Behavior and Cognition (8164) Biochemistry (19027) Bioengineering (15171) Bioinformatics (46171) Biophysics (22958) Cancer Biology (20384) Cell Biology (27663) Clinical Trials (138) Developmental Biology (14303) Ecology (21654) Epidemiology (2067) Evolutionary Biology (26065) Genetics (16504) Genomics (24125) Immunology (19291) Microbiology (43761) Molecular Biology (18610) Neuroscience (96424) Paleontology (719) Pathology (3082) Pharmacology and Toxicology (5288) Physiology (8389) Plant Biology (16488) Scientific Communication and Education (2128) Synthetic Biology (4705) Systems Biology (10504) Zoology (2447)
## Related Clinical Research

- [Mavacamten inhibits diaphragm myosin in vitro, with greater potency on slow fibers](https://medichelpline.com/clinical-feed/biorxiv-0-beta-myosin-inhibition-in-skeletal-muscle-impact-of-mavacamten-on-the-diaphragm.md)
- [Expert Disagreement and Ground Truth in Pathology AI: Impact on Clinical Relevance](https://medichelpline.com/clinical-feed/medrxiv-4-beyond-consensus-human-ground-truth-expert-disagreement-and-clinical-relevance.md)
- [Hyperbaric Oxygen Therapy Did Not Alter Endocannabinoid Markers or LPS After 10 Sessions](https://medichelpline.com/clinical-feed/pubmed-43059161.md) (DOI: 10.12659/MSM.953923)
- [Liability-threshold rare-variant test (LTBT) links HTRA3 to idiopathic pulmonary fibrosis](https://medichelpline.com/clinical-feed/medrxiv-9-a-new-liability-based-rare-variant-burden-test-identifies-a-novel-genetic.md)
- [Sugammadex versus Neostigmine for Early Pulmonary Recovery After Thoracoscopic Lung Resection](https://medichelpline.com/clinical-feed/pubmed-43036898.md) (DOI: 10.1080/07853890.2026.2763165)

## Navigation
- [← Back to Pulmonology Feed](https://medichelpline.com/clinical-feed/pulmonology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.